Northwest Biotherapeutics Inc (NWBO.OB) Defensive As Stock Drops
Share prices for Northwest Biotherapeutics Inc. (OTCBB: NWBO) dropped another 16 percent today, continuing the stock's week-long drop ever since the company unveiled its new DCVax brain cancer vaccine. In fact, shares have dropped so much over the past week that the company tried to assuage shareholders today regarding "certain media reports" as well as the company's "absence" of stock sales activity."Certain media reports have erroneously stated that company shareholders Toucan Capital and/or Toucan Partners have sold shares in the company at the time of the PIPE financing in April 2006, at the time of the recent AIM financing, or…